Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions
| Status: | Completed |
|---|---|
| Conditions: | Breast Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - 45 |
| Updated: | 1/25/2018 |
| Start Date: | March 2008 |
| End Date: | April 2008 |
A Single Dose, 2-Period, 2-Treatment 2-Way Crossover Bioequivalency Study of Letrozole Tablets Under Fasted Conditions
The objective of this study was to prove the bioequivalence of Letrozole Tablet under fasted
conditions.
conditions.
Inclusion Criteria:
- No clinically significant abnormal findings on the physical examination, medical history,
or clinical laboratory results during screening
Exclusion Criteria:
- Positive test for HIV, Hepatitis B, or Hepatitis C.
- Treatment with known enzyme altering drugs.
- History of allergic or adverse response to letrozole or any comparable or similar
product.
We found this trial at
1
site
Click here to add this to my saved trials
